The drug is contraindicated in people with moderate to severe liver impairment, active liver diseases, and unexplained high levels of transaminase liver enzymes.
Mipomersen
Acebutolol
Lumasiran
Eluxadoline
Mitapivat
Fabomotizole
Orlistat
Casimersen